Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis
about
Immune modulation during latent herpesvirus infectionDefining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusInfectious MononucleosisThe virome in host health and diseaseHuman memory T cells: generation, compartmentalization and homeostasisAmino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell RepertoireProtective Efficacy of Cross-Reactive CD8+ T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation ThresholdDisparate Epitopes Mediating Protective Heterologous Immunity to Unrelated Viruses Share Peptide-MHC Structural Features Recognized by Cross-Reactive T CellsLack of heterologous cross-reactivity towards HLA-A*02:01 restricted viral epitopes is underpinned by distinct αβT cell receptor signaturesInfectious mononucleosis.Quantitating T cell cross-reactivity for unrelated peptide antigensStructural allele-specific patterns adopted by epitopes in the MHC-I cleft and reconstruction of MHC:peptide complexes to cross-reactivity assessmentPC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cellsEstimating the diversity, completeness, and cross-reactivity of the T cell repertoire.Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infantsTemporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.Heterologous immunity between virusesAnalysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.Relationship between Poor Immunogenicity of HLA-A2-Restricted Peptide Epitopes and Paucity of Naïve CD8(+) T-Cell Precursors in HLA-A2-Transgenic Mice.Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.Bi-specific MHC heterodimers for characterization of cross-reactive T cellsLoss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.Coordinated regulation of NK receptor expression in the maturing human immune system.Vaccination and heterologous immunity: educating the immune systemEarly virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age.CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans.Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4(+) and CD8(+) memory formation.A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV InfectionEpstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance.Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.Cross-reactivity of T cells and its role in the immune systemRecent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?
P2860
Q24624044-5C98527F-E7EA-4A79-B50F-50D7588D8D2CQ24645078-5F972124-357F-4805-A786-F290FE0F4BF7Q26783692-BA1A3453-3627-42AD-B9A6-2E9BA4853DFEQ26824795-634E4F83-4E29-4EF4-A19C-9EC89C0F069EQ26851748-58194A94-3680-4129-9907-0FA867F10398Q27485470-37FFB69B-D3F8-443E-820E-96399C082666Q27664060-1A9C3F35-6597-4146-A517-E17B5AA741C7Q27680365-DDF1BCD5-99B1-4A49-BFB5-B1913E734A23Q27728085-0AF7E882-6B3C-4412-BB1C-15DD6365B3A6Q28084340-7B9736FD-E0BC-4BD8-9C80-3B57C8BE8EC8Q28750512-4F61B71A-4E92-4E48-AF08-FD9D46DC4A54Q28752409-514D7A69-9D42-4FC5-B58E-2CF304C89CA6Q30353758-68AB236B-AB17-4C31-9FFE-58BC07D38E1CQ30427198-F307767F-3700-440B-85E8-99080B127878Q33357547-65FA2237-1E8E-440D-B28E-18364E76265DQ33754553-87CB3BCA-856D-4E2F-8F9E-3B27BBB625E3Q33787783-2ABE66B3-9330-4635-B3FF-0DA6EC1ABCABQ34030735-DB419021-7623-4D39-98FE-163A9FDBD65DQ34051846-EC9A2A28-29EB-4B54-965F-A7A64BA4B5F9Q34057942-1F4D01B4-7D59-4FC8-9234-8F1BE5A9DD3BQ34105729-1FCD6D99-4CF9-4BC2-AA45-FA55E772D058Q34159981-0FF24509-ED4D-4968-96A8-6F4EC3C75030Q34236896-22AE6132-FB7A-4D39-B957-7BFFA5F29165Q34246886-7D233A6E-699D-4EB7-9041-97F8ACF9F919Q34288498-784B7F26-B68C-46C5-BACF-457767D5C375Q34457915-1626C8CC-B1C5-496C-B6F6-C4EA6AA3407BQ34476273-5E5C2912-F350-4EBF-9C54-B51F3B9EAA1EQ35152750-65317294-E74B-4F29-B5AD-0138ED808AD7Q35223805-965BA668-C4A9-4442-A0FA-A6C04A0098C7Q35640962-C16B6FC5-94A6-41EB-A1F0-39381AF307A6Q35660783-1AA38FA2-4AAB-490F-B6C4-03F7B382393DQ35800948-E92545C6-9C73-479E-B891-DCAAB7C1EE79Q35826013-D42271C5-1C1D-4CF2-BDDC-01746F0DDFE9Q35889240-2EDF4929-F2A6-41D6-AF7F-56D56347062FQ36176987-6F9E8B9F-4EE5-4F32-8F94-7E1DC3BAF579Q36199894-7E17C69E-2207-44CE-9677-637FFDE33224Q36255850-45E189EB-1BC0-403E-BB22-AFF871BE1AD6Q36528984-67E1F9AF-1DE2-4C1C-8232-665F053E18D9Q36678774-417A9BF3-312D-4985-A91F-772DDDCE79DCQ36688962-9E973461-8F91-463C-B153-754FFB4BB82E
P2860
Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cross-reactive influenza virus ...... iated infectious mononucleosis
@ast
Cross-reactive influenza virus ...... iated infectious mononucleosis
@en
Cross-reactive influenza virus ...... iated infectious mononucleosis
@nl
type
label
Cross-reactive influenza virus ...... iated infectious mononucleosis
@ast
Cross-reactive influenza virus ...... iated infectious mononucleosis
@en
Cross-reactive influenza virus ...... iated infectious mononucleosis
@nl
prefLabel
Cross-reactive influenza virus ...... iated infectious mononucleosis
@ast
Cross-reactive influenza virus ...... iated infectious mononucleosis
@en
Cross-reactive influenza virus ...... iated infectious mononucleosis
@nl
P2093
P2860
P356
P1476
Cross-reactive influenza virus ...... iated infectious mononucleosis
@en
P2093
John L Sullivan
Katherine Luzuriaga
Levi B Watkin
Liisa K Selin
Markus Cornberg
Raymond M Welsh
Shalyn C Clute
Yuri N Naumov
P2860
P304
P356
10.1172/JCI25078
P407
P577
2005-11-23T00:00:00Z